Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg Tablets

Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg is a three-drug combination for high blood pressure requiring complementary treatment. It combines angiotensin-receptor blockade, calcium-channel blockade and a thiazide-like diuretic.
Take in the morning to reduce night-time urination, with or without food. Swallow with water. Each tablet changes all three component doses, so it should not be taken additionally to correct a single high reading.
Olmesartan blocks angiotensin II effects, amlodipine relaxes arterial smooth muscle, and chlorthalidone increases renal salt and water removal. Their complementary actions lower blood pressure.
Dizziness, ankle swelling, increased urination, headache and sodium or potassium changes can occur. Severe weakness, fainting, palpitations or reduced urination requires assessment.
Do not use during pregnancy. Dehydration, significant kidney dysfunction and gout are important. Electrolytes and kidney function are monitored. NSAIDs, lithium, potassium products and other blood-pressure medicines can produce important interactions.
Consolidates three complementary antihypertensive mechanisms when the intended regimen requires all three components.
Yes. The amounts refer to three different active ingredients, not alternative strengths of one medicine.
Amlodipine can cause local ankle oedema, while the diuretic can reduce circulating volume. These are different processes.
Not reliably. A different combination strength or separate component adjustment is needed to alter only one ingredient.
Yes. ARB and diuretic effects can move potassium in different directions, so laboratory monitoring is important.
No. Severe hypertension with acute symptoms needs urgent assessment rather than an extra fixed-dose tablet.
Fixed-dose combination: a product containing set amounts of multiple medicines. Thiazide-like diuretic: a medicine increasing renal salt excretion. Orthostatic hypotension: blood-pressure reduction on standing; AR: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg أقراص; FR: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg comprimés; PT: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg comprimidos; ES: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg comprimidos; RU: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg таблетки; ID: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg tablet; VI: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg viên nén; MS: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg tablet; TL: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg tableta; ZH-SG: Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Olmesartan Medoxomil 20mg + Amlodipine 5mg + Chlorthalidone 12.5mg Tablets